Biocure Technology Inc. (CSE:CURE.X)
Canada
· Delayed Price · Currency is CAD 0.0400
+0.0150 (60.00%)
At close: Apr 14, 2025
Biocure Technology Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2015 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2015 - 2018 |
| Net Income | -4.06 | -1.81 | -1.45 | -1.13 | -2.95 | -4.74 | Upgrade
|
| Depreciation & Amortization | - | - | - | - | 0.05 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.74 | 0.74 | - | - | -0 | 0 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.18 | 0.18 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 1.16 | 0.11 | 1.58 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.72 | 0.72 | - | - | - | - | Upgrade
|
| Other Operating Activities | 2.3 | -0.11 | 0.75 | -0.74 | -0.24 | 0.04 | Upgrade
|
| Change in Accounts Receivable | 0 | 0.02 | -0.01 | -0.01 | 0.02 | -0.06 | Upgrade
|
| Change in Inventory | - | - | - | - | 0.01 | 0.01 | Upgrade
|
| Change in Accounts Payable | 0.19 | 0.24 | 0.45 | 0.3 | 1.79 | 0.44 | Upgrade
|
| Change in Other Net Operating Assets | 0 | - | 0.06 | -0.05 | -0.02 | 0 | Upgrade
|
| Operating Cash Flow | 0.07 | -0.22 | -0.83 | -1.08 | -1.31 | -2.68 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0 | - | Upgrade
|
| Other Investing Activities | - | -0 | -0 | 0.45 | - | - | Upgrade
|
| Investing Cash Flow | - | 0.04 | 0.07 | 0.03 | 0.09 | -1.05 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.4 | 1.99 | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.4 | 1.99 | Upgrade
|
| Long-Term Debt Repaid | - | -0.05 | - | - | -0.25 | -0.06 | Upgrade
|
| Total Debt Repaid | -0.05 | -0.05 | - | - | -0.25 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | -0.05 | -0.05 | - | - | 0.15 | 1.93 | Upgrade
|
| Issuance of Common Stock | - | - | - | 0.93 | 0.25 | - | Upgrade
|
| Other Financing Activities | -0 | 0.19 | 0.63 | 0.24 | 0.74 | 1.76 | Upgrade
|
| Financing Cash Flow | -0.05 | 0.14 | 0.63 | 1.17 | 1.13 | 3.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | - | - | -0 | -0 | 0.06 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 0.02 | -0.03 | -0.12 | 0.11 | -0.09 | 0.02 | Upgrade
|
| Free Cash Flow | 0.07 | -0.22 | -0.83 | -1.08 | -1.31 | -2.68 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | -0.02 | -0.07 | -0.10 | -0.12 | -0.25 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.02 | 0.03 | 0.03 | Upgrade
|
| Levered Free Cash Flow | -0.31 | -4.58 | 4.59 | -3.5 | -0.36 | -0.98 | Upgrade
|
| Unlevered Free Cash Flow | -0.31 | -4.58 | 4.59 | -3.46 | -0.21 | -0.89 | Upgrade
|
| Change in Net Working Capital | -0.29 | 3.93 | -5.01 | 3.54 | -1.54 | -0.33 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.